STATE STREET CORP - LYELL IMMUNOPHARMA INC ownership

LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 99 filers reported holding LYELL IMMUNOPHARMA INC in Q2 2023. The put-call ratio across all filers is 11.33 and the average weighting 0.8%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of LYELL IMMUNOPHARMA INC
ValueSharesWeighting
Q3 2023$10,011,329
-49.0%
6,810,428
+10.4%
0.00%0.0%
Q2 2023$19,624,559
+5.0%
6,171,245
-22.1%
0.00%0.0%
Q1 2023$18,694,155
-69.2%
7,921,252
-54.7%
0.00%
-50.0%
Q4 2022$60,727,908
+54.0%
17,500,838
+225.3%
0.00%0.0%
Q3 2022$39,434,000
+133.0%
5,379,838
+107.2%
0.00%
+100.0%
Q2 2022$16,925,000
+77.2%
2,595,919
+37.3%
0.00%
Q1 2022$9,549,000
+194.4%
1,890,929
+351.1%
0.00%
Q4 2021$3,244,000
-22.8%
419,184
+47.7%
0.00%
Q3 2021$4,200,000283,8020.00%
Other shareholders
LYELL IMMUNOPHARMA INC shareholders Q2 2023
NameSharesValueWeighting ↓
MWG Management Ltd. 20,329,235$330,147,00032.44%
Apoletto Ltd 15,167,757$246,324,00032.33%
Foresite Capital Management IV, LLC 13,282,181$215,703,00029.16%
Kirkoswald Asset Management LLC 1,000$16,0009.88%
MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC 1,320,000$21,436,800,0003.90%
HSG Holding Ltd 2,436,798$39,574,0002.76%
Board of Trustees of The Leland Stanford Junior University 1,647,882$26,761,0002.50%
Alphabet Inc. 5,865,125$95,250,0001.94%
Arena Capital Advisors, LLC- CA 545,137$8,853,0000.73%
SB Management Ltd 3,500,000$56,840,0000.67%
View complete list of LYELL IMMUNOPHARMA INC shareholders